Bulletin
Investor Alert

BioLine RX Ltd. ADR

NAS: BLRX

GO
/marketstate/country/us

Market closed

/zigman2/quotes/206459058/composite

$

1.23

Change

-0.07 -5.38%

Volume

Volume 176,626

Jun 29, 2022, 3:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206459058/composite

Previous close

$ 1.30

$ 1.23

Change

-0.07 -5.38%

Day low

Day high

$1.20

$1.27

Open
Open: 1.25

52 week low

52 week high

$1.01

$3.62

Open

Market cap

$64.16M

Average volume

178,708

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.47

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/blrx

MarketWatch News on BLRX

  1. BioLine RX stock price target cut to $7 from $10 at Oppenheimer

    7:19 a.m. May 12, 2022

    - Tomi Kilgore

  2. BioLine RX stock price target raised to $10 from $5 at Maxim Group

    2:09 p.m. May 4, 2021

    - Tomi Kilgore

  3. BioLine RX started at outperform with $3 stock price target at Oppenheimer

    8:21 a.m. Aug. 4, 2017

    - Tomi Kilgore

  4. BioLine RX stock price target cut to $1 from $4 at Maxim Group

    7:23 a.m. Aug. 12, 2016

    - Tomi Kilgore

  5. Cancer Therapy May See Major Shift

    8:34 a.m. March 17, 2016

    - Barron's Online

  6. Darden shares rise after earnings beat

    7:38 p.m. Dec. 16, 2014

    - Wallace Witkowski

  7. BioLineRx's stock soars 17% premarket after collaboration pact with Novartis Pharma

    8:13 a.m. Dec. 16, 2014

    - Tomi Kilgore

  8. Three Biotechs Ready to Partner Up

    10:30 a.m. Sept. 8, 2014

    - Barron's Online

  9. Monday’s biggest gaining and declining stocks

    6:41 p.m. Sept. 25, 2012

    - Greg Morcroft

  10. Tuesday’s biggest gaining and declining stocks

    5:09 p.m. Sept. 25, 2012

    - Greg Morcroft

  11. Stocks to Watch Wednesday: Jabil Circuit

    4:37 p.m. Sept. 25, 2012

    - David B. Wilkerson

  12. Vertex to advance testing of oral HCV drug regimen

    10:34 a.m. Sept. 25, 2012

    - Val Brickates Kennedy

  13. BioLine up 16% on schizophrenia patent move

    9:21 a.m. Sept. 24, 2012

    - Steve Gelsi

  14. BioLine RX rallies 15% in premarket

    9:10 a.m. Sept. 24, 2012

    - Steve Gelsi

  15. BioLine gets U.S. patent for schizophrenia drug

    8:54 a.m. Sept. 24, 2012

    - Greg Morcroft

  16. BioLine RX shares jump 36%

    8:52 a.m. Sept. 24, 2012

    - Greg Morcroft

  17. Achillion, Idenix move on price target changes

    10:29 a.m. Sept. 19, 2012

    - Val Brickates Kennedy

  18. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/blrx

Other News on BLRX

  1. biolinerx GAAP EPS of -$0.04 beats by $0.42

    7:07 a.m. March 16, 2022

    - Seeking Alpha

  2. BLRX, EOSE and SPIR among premarket gainers

    9:35 a.m. March 3, 2022

    - Seeking Alpha

  3. PSTI, BLRX and BBIG among pre-market gainers

    9:18 a.m. Jan. 18, 2022

    - Seeking Alpha

  4. INDI, NTP and VSTA among mid-day movers

    1:21 p.m. Dec. 10, 2021

    - Seeking Alpha

  5. biolinerx EPS beats by $0.11

    8:06 a.m. Nov. 18, 2021

    - Seeking Alpha

  6. 2021 Top Idea Contest - New Ideas

    11:53 a.m. July 29, 2021

    - Seeking Alpha

  7. WB, OCGN among premarket gainers

    8:30 a.m. July 6, 2021

    - Seeking Alpha

  8. Microcaps mostly among premarkets gainers

    8:24 a.m. July 1, 2021

    - Seeking Alpha

  9. Loading more headlines...
/news/pressrelease/company/us/blrx

Press Releases on BLRX

  1. BioLineRx to Report First Quarter 2022 Results on May 11, 2022

    7:00 a.m. May 5, 2022

    - PR Newswire - PRF

  2. BioLineRx to Report 2021 Annual Results on March 16, 2022

    8:00 a.m. March 10, 2022

    - PR Newswire - PRF

  3. BioLineRx to Report Third Quarter 2021 Results on November 18, 2021

    8:16 a.m. Nov. 12, 2021

    - PR Newswire - PRF

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.